Kitov Pharma to Present at the H.C. Wainwright 21s
Post# of 35
GlobeNewswire•September 3, 2019
TEL AVIV, Israel, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that Isaac Israel, CEO, and Gil Efron, Deputy CEO and CFO, will participate in the H.C. Wainwright 21st Annual Healthcare Conference that is being held in New York on September 8-10, 2019.
Mr. Israel will provide an overview of Kitov’s business strategy and pipeline during the live presentation. They will also participate in one-on-one meetings with investors who are registered to attend the conference.
Details of presentation are as follows:
H.C. Wainwright Annual Healthcare Conference
Presentation Date: September 10, 2019
Presentation Time: 12:05 p.m. – 12:30 p.m. ET
Location: Lotte New York Palace Hotel, New York, USA
The updated Kitov corporate presentation will be made available on the “Investor Relations” section on the Kitov website at http://kitovpharma.investorroom.com/presentations
https://finance.yahoo.com/news/kitov-pharma-p...00723.html